Concepts (174)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Hypertension, Pulmonary | 9 | 2019 | 78 | 2.880 |
Why?
|
| Anemia, Sickle Cell | 8 | 2019 | 185 | 2.340 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 5 | 2022 | 164 | 1.700 |
Why?
|
| Asthma | 7 | 2022 | 410 | 1.450 |
Why?
|
| Body Mass Index | 3 | 2017 | 916 | 0.820 |
Why?
|
| Pneumonia | 2 | 2021 | 60 | 0.810 |
Why?
|
| Influenza, Human | 2 | 2021 | 90 | 0.790 |
Why?
|
| Middle Aged | 27 | 2023 | 11819 | 0.660 |
Why?
|
| Intensive Care Units | 2 | 2017 | 71 | 0.640 |
Why?
|
| Nutrition Surveys | 6 | 2022 | 263 | 0.630 |
Why?
|
| United States | 19 | 2024 | 5072 | 0.630 |
Why?
|
| Obesity | 3 | 2017 | 1131 | 0.630 |
Why?
|
| Sleep Apnea Syndromes | 3 | 2019 | 27 | 0.620 |
Why?
|
| Aged | 19 | 2021 | 7982 | 0.620 |
Why?
|
| Male | 31 | 2023 | 22779 | 0.620 |
Why?
|
| Vital Capacity | 2 | 2018 | 44 | 0.610 |
Why?
|
| Hospitalization | 4 | 2021 | 482 | 0.610 |
Why?
|
| Forced Expiratory Volume | 2 | 2018 | 75 | 0.600 |
Why?
|
| Sepsis | 2 | 2019 | 90 | 0.600 |
Why?
|
| Aged, 80 and over | 13 | 2021 | 2803 | 0.590 |
Why?
|
| Female | 32 | 2024 | 24018 | 0.590 |
Why?
|
| Humans | 42 | 2024 | 42163 | 0.590 |
Why?
|
| Lung | 3 | 2017 | 484 | 0.590 |
Why?
|
| Adult | 25 | 2024 | 13458 | 0.570 |
Why?
|
| Nitric Oxide | 4 | 2022 | 381 | 0.550 |
Why?
|
| Risk Factors | 11 | 2024 | 3942 | 0.530 |
Why?
|
| Hemodynamics | 2 | 2017 | 101 | 0.530 |
Why?
|
| Critical Illness | 1 | 2017 | 46 | 0.520 |
Why?
|
| Tobacco, Smokeless | 1 | 2016 | 19 | 0.490 |
Why?
|
| Prevalence | 8 | 2024 | 1597 | 0.490 |
Why?
|
| Expiratory Reserve Volume | 1 | 2015 | 2 | 0.490 |
Why?
|
| Functional Residual Capacity | 1 | 2015 | 2 | 0.490 |
Why?
|
| Pulmonary Eosinophilia | 1 | 2015 | 5 | 0.480 |
Why?
|
| Hospital Mortality | 4 | 2021 | 206 | 0.470 |
Why?
|
| Pulmonary Embolism | 1 | 2016 | 38 | 0.470 |
Why?
|
| Tobacco Smoke Pollution | 1 | 2015 | 54 | 0.470 |
Why?
|
| Health Resources | 1 | 2015 | 37 | 0.450 |
Why?
|
| Atrial Fibrillation | 1 | 2016 | 121 | 0.440 |
Why?
|
| Cause of Death | 5 | 2019 | 183 | 0.400 |
Why?
|
| Health Status Disparities | 6 | 2021 | 705 | 0.380 |
Why?
|
| Retrospective Studies | 5 | 2021 | 2485 | 0.380 |
Why?
|
| Dementia | 1 | 2013 | 155 | 0.370 |
Why?
|
| Smoking | 2 | 2020 | 1019 | 0.360 |
Why?
|
| Comorbidity | 5 | 2018 | 725 | 0.350 |
Why?
|
| Survival Analysis | 4 | 2018 | 362 | 0.340 |
Why?
|
| Prognosis | 3 | 2018 | 850 | 0.320 |
Why?
|
| Sarcoidosis | 2 | 2019 | 11 | 0.290 |
Why?
|
| Survival Rate | 3 | 2017 | 353 | 0.250 |
Why?
|
| Alzheimer Disease | 1 | 2013 | 972 | 0.240 |
Why?
|
| Respiratory Function Tests | 2 | 2016 | 61 | 0.240 |
Why?
|
| Wounds and Injuries | 2 | 2018 | 191 | 0.240 |
Why?
|
| Young Adult | 7 | 2019 | 4936 | 0.220 |
Why?
|
| Quality-Adjusted Life Years | 4 | 2018 | 76 | 0.220 |
Why?
|
| Proportional Hazards Models | 2 | 2018 | 512 | 0.220 |
Why?
|
| Sex Distribution | 4 | 2019 | 224 | 0.210 |
Why?
|
| Sleep Initiation and Maintenance Disorders | 2 | 2015 | 70 | 0.210 |
Why?
|
| Exhalation | 3 | 2022 | 10 | 0.210 |
Why?
|
| Breath Tests | 3 | 2022 | 24 | 0.210 |
Why?
|
| Multivariate Analysis | 2 | 2016 | 638 | 0.200 |
Why?
|
| Age Factors | 3 | 2017 | 1139 | 0.200 |
Why?
|
| Sex Factors | 3 | 2017 | 1008 | 0.200 |
Why?
|
| Pregnancy Complications, Infectious | 1 | 2024 | 112 | 0.200 |
Why?
|
| Cognition | 2 | 2017 | 458 | 0.190 |
Why?
|
| Urbanization | 2 | 2019 | 13 | 0.190 |
Why?
|
| Adolescent | 7 | 2019 | 5950 | 0.190 |
Why?
|
| Child | 7 | 2019 | 3381 | 0.180 |
Why?
|
| Age Distribution | 3 | 2018 | 249 | 0.180 |
Why?
|
| Respiration, Artificial | 1 | 2021 | 47 | 0.170 |
Why?
|
| Logistic Models | 2 | 2014 | 1001 | 0.170 |
Why?
|
| Cardiovascular Diseases | 2 | 2018 | 729 | 0.170 |
Why?
|
| Pulmonary Diffusing Capacity | 2 | 2019 | 5 | 0.160 |
Why?
|
| Databases, Factual | 1 | 2021 | 336 | 0.150 |
Why?
|
| Diarrhea | 2 | 2016 | 95 | 0.150 |
Why?
|
| Lung Diseases | 1 | 2019 | 62 | 0.150 |
Why?
|
| Cohort Studies | 3 | 2024 | 1729 | 0.140 |
Why?
|
| Practice Guidelines as Topic | 1 | 2019 | 225 | 0.140 |
Why?
|
| Toxocara | 1 | 2017 | 1 | 0.140 |
Why?
|
| Toxocariasis | 1 | 2017 | 2 | 0.140 |
Why?
|
| Hypercalcemia | 1 | 2018 | 13 | 0.140 |
Why?
|
| Morbidity | 1 | 2018 | 97 | 0.140 |
Why?
|
| Research | 1 | 2019 | 177 | 0.140 |
Why?
|
| Respiratory Tract Diseases | 1 | 2018 | 30 | 0.140 |
Why?
|
| Pancreatitis | 1 | 2018 | 21 | 0.140 |
Why?
|
| Airway Obstruction | 1 | 2017 | 9 | 0.140 |
Why?
|
| Television | 1 | 2017 | 28 | 0.130 |
Why?
|
| District of Columbia | 1 | 2017 | 73 | 0.130 |
Why?
|
| Predictive Value of Tests | 1 | 2018 | 438 | 0.130 |
Why?
|
| Epoprostenol | 1 | 2017 | 28 | 0.130 |
Why?
|
| Gout | 1 | 2017 | 16 | 0.130 |
Why?
|
| Osteoarthritis | 1 | 2017 | 25 | 0.130 |
Why?
|
| Time Factors | 3 | 2017 | 1848 | 0.130 |
Why?
|
| Forecasting | 1 | 2017 | 136 | 0.130 |
Why?
|
| Social Problems | 1 | 2016 | 14 | 0.130 |
Why?
|
| Arthritis, Rheumatoid | 1 | 2017 | 53 | 0.130 |
Why?
|
| Neck Pain | 1 | 2017 | 59 | 0.130 |
Why?
|
| Atrial Flutter | 1 | 2016 | 7 | 0.130 |
Why?
|
| Respiratory Sounds | 1 | 2016 | 12 | 0.120 |
Why?
|
| Residual Volume | 1 | 2015 | 2 | 0.120 |
Why?
|
| Total Lung Capacity | 1 | 2015 | 5 | 0.120 |
Why?
|
| Vascular Resistance | 1 | 2015 | 37 | 0.120 |
Why?
|
| Length of Stay | 1 | 2017 | 231 | 0.120 |
Why?
|
| Echocardiography | 2 | 2017 | 167 | 0.120 |
Why?
|
| Sleep | 1 | 2017 | 179 | 0.120 |
Why?
|
| Low Back Pain | 1 | 2017 | 100 | 0.120 |
Why?
|
| Ventricular Remodeling | 1 | 2015 | 58 | 0.110 |
Why?
|
| Vital Statistics | 1 | 2014 | 7 | 0.110 |
Why?
|
| Follow-Up Studies | 2 | 2017 | 1051 | 0.110 |
Why?
|
| Antihypertensive Agents | 1 | 2017 | 285 | 0.110 |
Why?
|
| Snoring | 1 | 2014 | 9 | 0.110 |
Why?
|
| Depressive Disorder | 1 | 2015 | 185 | 0.100 |
Why?
|
| Confidence Intervals | 1 | 2014 | 162 | 0.100 |
Why?
|
| Pulmonary Wedge Pressure | 1 | 2013 | 7 | 0.100 |
Why?
|
| Health Status | 1 | 2017 | 432 | 0.100 |
Why?
|
| Echocardiography, Doppler | 1 | 2013 | 41 | 0.100 |
Why?
|
| Mediterranean Region | 3 | 2017 | 6 | 0.100 |
Why?
|
| Incidence | 1 | 2016 | 1054 | 0.100 |
Why?
|
| Attitude to Health | 1 | 2015 | 336 | 0.100 |
Why?
|
| Patient Discharge | 1 | 2013 | 131 | 0.100 |
Why?
|
| Child, Preschool | 4 | 2018 | 1516 | 0.100 |
Why?
|
| Emergency Service, Hospital | 1 | 2015 | 268 | 0.100 |
Why?
|
| Mental Disorders | 1 | 2017 | 377 | 0.100 |
Why?
|
| Heart Failure | 1 | 2016 | 298 | 0.090 |
Why?
|
| Interviews as Topic | 1 | 2014 | 428 | 0.090 |
Why?
|
| Health Surveys | 1 | 2014 | 401 | 0.090 |
Why?
|
| Pulmonary Fibrosis | 1 | 2012 | 38 | 0.090 |
Why?
|
| Diagnostic Imaging | 1 | 2012 | 53 | 0.090 |
Why?
|
| Coronary Disease | 1 | 2012 | 123 | 0.090 |
Why?
|
| Clinical Trials as Topic | 1 | 2013 | 249 | 0.090 |
Why?
|
| Mortality | 3 | 2018 | 174 | 0.080 |
Why?
|
| Risk Assessment | 1 | 2013 | 845 | 0.080 |
Why?
|
| Healthcare Disparities | 1 | 2015 | 573 | 0.080 |
Why?
|
| Socioeconomic Factors | 1 | 2014 | 1221 | 0.080 |
Why?
|
| Infant | 3 | 2018 | 1143 | 0.080 |
Why?
|
| Death Certificates | 2 | 2018 | 15 | 0.070 |
Why?
|
| Middle East | 2 | 2017 | 21 | 0.070 |
Why?
|
| Neoplasms | 1 | 2018 | 1341 | 0.070 |
Why?
|
| Cost of Illness | 2 | 2018 | 95 | 0.060 |
Why?
|
| Life Expectancy | 2 | 2017 | 69 | 0.060 |
Why?
|
| Infant, Newborn | 2 | 2017 | 960 | 0.050 |
Why?
|
| Fatigue | 1 | 2023 | 97 | 0.050 |
Why?
|
| Severity of Illness Index | 1 | 2024 | 708 | 0.050 |
Why?
|
| New Jersey | 1 | 2021 | 15 | 0.040 |
Why?
|
| New York | 1 | 2021 | 88 | 0.040 |
Why?
|
| Disease Progression | 1 | 2023 | 661 | 0.040 |
Why?
|
| Acute Chest Syndrome | 1 | 2019 | 2 | 0.040 |
Why?
|
| Tidal Volume | 1 | 2019 | 9 | 0.040 |
Why?
|
| Societies, Medical | 1 | 2019 | 74 | 0.040 |
Why?
|
| Evidence-Based Medicine | 1 | 2019 | 107 | 0.040 |
Why?
|
| Disease Management | 1 | 2019 | 68 | 0.040 |
Why?
|
| Prospective Studies | 1 | 2023 | 1574 | 0.040 |
Why?
|
| Pregnancy | 1 | 2024 | 1737 | 0.040 |
Why?
|
| Antibodies, Helminth | 1 | 2017 | 24 | 0.030 |
Why?
|
| Lectins, C-Type | 1 | 2017 | 37 | 0.030 |
Why?
|
| Respiratory System | 1 | 2017 | 31 | 0.030 |
Why?
|
| Antigens, Helminth | 1 | 2017 | 34 | 0.030 |
Why?
|
| Djibouti | 1 | 2017 | 2 | 0.030 |
Why?
|
| Somalia | 1 | 2017 | 3 | 0.030 |
Why?
|
| Spirometry | 1 | 2017 | 40 | 0.030 |
Why?
|
| Africa, Northern | 1 | 2017 | 6 | 0.030 |
Why?
|
| Diagnosis, Differential | 1 | 2018 | 236 | 0.030 |
Why?
|
| Musculoskeletal Diseases | 1 | 2017 | 18 | 0.030 |
Why?
|
| Africa | 1 | 2016 | 81 | 0.030 |
Why?
|
| Immunoglobulin G | 1 | 2017 | 253 | 0.030 |
Why?
|
| Cardiac Volume | 1 | 2015 | 4 | 0.030 |
Why?
|
| Cardiac Output | 1 | 2015 | 24 | 0.030 |
Why?
|
| Ventricular Function, Right | 1 | 2015 | 33 | 0.030 |
Why?
|
| Heart Rate | 1 | 2015 | 261 | 0.030 |
Why?
|
| Poverty | 1 | 2017 | 395 | 0.030 |
Why?
|
| Blood Pressure | 1 | 2017 | 662 | 0.030 |
Why?
|
| Treatment Outcome | 1 | 2017 | 1586 | 0.020 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2015 | 577 | 0.020 |
Why?
|
| Aging | 1 | 2016 | 764 | 0.020 |
Why?
|
| Algorithms | 1 | 2012 | 508 | 0.020 |
Why?
|
| Animals | 1 | 2017 | 16695 | 0.010 |
Why?
|